CytomX Therapeutics (CTMX) Capital Expenditures (QoQ) (2015 - 2025)
CytomX Therapeutics (CTMX) Capital Expenditures (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 258.27% |
| Sep 30, 2025 | -570.37% |
| Jun 30, 2025 | -77.31% |
| Mar 31, 2025 | 48.75% |
| Dec 31, 2024 | 321.05% |
| Sep 30, 2024 | -80.21% |
| Jun 30, 2024 | -16.52% |
| Mar 31, 2024 | 123.05% |
| Dec 31, 2023 | -5,644.44% |
| Sep 30, 2023 | -98.26% |
| Jun 30, 2023 | 977.08% |
| Mar 31, 2023 | -73.63% |
| Dec 31, 2022 | -55.61% |
| Sep 30, 2022 | -0.49% |
| Jun 30, 2022 | -44.02% |
| Mar 31, 2022 | 200.41% |
| Dec 31, 2021 | -8.58% |
| Sep 30, 2021 | 135.09% |
| Jun 30, 2021 | -88.39% |
| Mar 31, 2021 | 156.37% |